Please login to the form below
Norway
This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
Decision time for Brexit
While warning of the dangers of a no deal Brexit, the ABPI’s chief executive Mike Thompson has also made it clear that he also doesn’t favour a ‘Norway
Latest news
-
‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario
Exiting the EU without a deal would mean also exiting the European Medicines Agency’s pan-European (28 EU countries plus Iceland, Norway and Liechtenstein) approval system.
-
MHRA cut out of regulatory work as Brexit looms
In April, the EMA re-allocated responsibility for more than 370 centrally authorised products to new rapporteurs and co-rapporteurs from the EU27 plus Iceland and Norway.
-
Pharma survey: No Brexit is the best option
Norway model' being the most selected option (17%).
-
AZ gets US approval for Veltassa rival Lokelma
year and so far include Norway, the UK, Denmark and Germany.
-
AZ finally gets EU nod for Veltassa rival Lokelma
It was approved in the EU last July and as of the end of 2017 had been launched in the UK, Norway and Denmark.
More from news
Approximately 1 fully matching, plus 128 partially matching documents found.
Latest Intelligence
-
The case for a second Brexit referendum: “We need the informed consent of the people”
As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.
-
The tipping point
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
-
Building a bright future
We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing
-
Pharma deals continue to slide
For example this month, Karo Pharma, Sweden acquired Weifa, Norway for $163m for product and territory complementarity.
-
2016: The year when deal-makers took stock?
product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.). ... The rate of uptake of biosimilars in Norway is exceptional, but the upward trend in other countries is still
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest appointments
-
Gilead Sciences appoints general manager, Canada
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
-
Targovax appoints chief financial officer
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
-
Algeta execs join Targovax
Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
-
Anker Lundemose appointed CEO of Bionor Pharma
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
-
Matt Regan named AbbVie’s general manager in UK
Matt Regan named AbbVie’ s general manager in UK. Was formerly general manager of Abbott in Norway. ... Regan was formerly general manager for Abbott in Norway and will now oversee the new firm's UK presence as it establishes itself as a separate
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Compounding Pharmacies Market to Grow at a 5% CAGR to 2024
area-hormone-replacement-pain-management-industry-analysis-report-regional-outlook-u-s-canada-germany-uk-italy-france-spain-russia-poland-greece-ukraine-sweden-norway-belgium-czech-republic-finland-china-india-japan-
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Medical/ Scientific Director
-
Salary TBC
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Medical Writers
-
Competitive Salary and Benefits
-
Senior Medical Writer
-
Competitive Salary
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Account Manager / Account Director
-
Competative
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
New Business Director - PR
-
Competitive Salary and benefits
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Senior Account Director development role to Business Director, H...
-
Excellent package
Subscribe to our email news alerts
- Behaviour change – a missing ingredient?
- Animal Health Diagnostics Market Forecast Showing 9.53% CAGR to 2022
- Iron Drugs Market Set to Register 9.27% CAGR to 2022
- Medical Device Manufacturing Outsourcing Market to Soar at 11.92% CAGR to 2022
- Plaque Modification Devices Market Forecast Showing 8.19% CAGR to 2022
- Radiotherapy Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2023
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
